ENZO BIOCHEM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enzo Biochem, Inc.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Enzo Biochem, Inc. (OTC: ENZB) to Battery Ventures. Under the terms of the proposed transaction, shareholders of Enzo will receive $0.70 in cash for each share of Enzo that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/otc-enzb/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
34 minutes ago
- Business Wire
Community Trust Bancorp, Inc. Announces the Appointment of David L. Baird to Its Board of Directors
PIKEVILLE, Ky.--(BUSINESS WIRE)--Community Trust Bancorp, Inc. (NASDAQ: CTBI) is pleased to announce the appointment of David L. Baird to its Board of Directors. A native of Pikeville, Kentucky, Mr. Baird is an attorney and shareholder at Baird & Baird, P.S.C. in Pikeville, Kentucky. He earned a Bachelor of Science degree from the Richard T. Farmer School of Business at Miami University (Ohio). He earned his Juris Doctor from the Salmon P. Chase College of Law at Northern Kentucky University in Highland Heights, Kentucky. Mr. Baird's legal practice has concentrated on Mineral and Environmental Law, Real Property and Contract Litigation, Business Transactions, Bankruptcy (Creditor) and General Practice. He is a member of the Kentucky Bar Association and the Pike County Bar Association. He is admitted to practice in all courts in the Commonwealth of Kentucky, the United States District Courts in both the Western and Eastern District of Kentucky, and the United States Court of Appeals for the Sixth Circuit. Mr. Baird is a member of the Board Directors of Pikeville Medical Center, Inc., The Elliott Company, Hocker Developments, Inc., and the Pike County Regional Airport Board. He was a member of the Board of Directors of the Southeast Kentucky Chamber of Commerce from 2014 through 2019, serving as its Chairman in 2018. He also serves on the Board of Sandy Valley Habitat for Humanity, The Rotary Club of Pikeville and regional education initiative, Community Economic Development and Revitalization (CEDAR). He and his wife Lisa live in Pikeville with their three children where they are members of the Pikeville United Methodist Church. "We are very pleased to have Mr. Baird join the Board of Directors of Community Trust Bancorp, Inc. He brings a level of experience and knowledge which makes him a valuable addition to our Board," said Mark A. Gooch, Chairman, President and CEO of Community Trust Bancorp, Inc. Community Trust Bancorp, Inc., with assets of $6.3 billion, is headquartered in Pikeville, Kentucky and has 72 banking locations across eastern, northeastern, central, and south central Kentucky, six banking locations in southern West Virginia, three banking locations in Tennessee, four trust offices across Kentucky, and one trust office in Tennessee.
Business Wire
41 minutes ago
- Business Wire
Douglas Emmett Announces Dates for Its 2025 Second Quarter Earnings Results and Live Conference Call
SANTA MONICA, Calif.--(BUSINESS WIRE)--Douglas Emmett, Inc. (NYSE:DEI), a real estate investment trust (REIT), announced today that it plans to release its 2025 second quarter earnings results after market close on Tuesday, August 5, 2025. A live conference call is scheduled for the following day, Wednesday, August 6, 2025, at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time. Jordan Kaplan, President and Chief Executive Officer, will host the call along with Peter Seymour, Chief Financial Officer, Kevin Crummy, Chief Investment Officer, and Stuart McElhinney, Vice President Investor Relations. Interested parties can listen to the call via the following: INTERNET: Go to at least fifteen minutes prior to the start time of the call in order to register, download and install any necessary audio software. PHONE: 888-349-0488 (U.S.) or 412-542-4156 (International). Please ask to join the Douglas Emmett, Inc. call. About Douglas Emmett, Inc. Douglas Emmett, Inc. (DEI) is a fully integrated, self-administered and self-managed real estate investment trust (REIT), and one of the largest owners and operators of high-quality office and multifamily properties located in the premier coastal submarkets of Los Angeles and Honolulu. Douglas Emmett focuses on owning and acquiring a substantial share of top-tier office properties and premier multifamily communities in neighborhoods that possess significant supply constraints, high-end executive housing and key lifestyle amenities. For more information about Douglas Emmett, please visit our website at Safe Harbor Statement Except for the historical facts, the statements in this press release regarding Douglas Emmett's business activities are forward-looking statements based on the beliefs of, assumptions made by, and information currently available to us about known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results can be expected to differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on forward-looking statements to anticipate future results or trends. For a discussion of some of the risks and uncertainties that could cause actual results to differ from those contained in the forward-looking statements, see 'Risk Factors' in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission.
Business Wire
an hour ago
- Business Wire
Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ('Bausch + Lomb' or the 'company'), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb Netherlands B.V. and Bausch & Lomb Incorporated (collectively, the 'Issuers'), have closed the upsized offering of €675 million aggregate principal amount of senior secured floating rate notes due 2031 (the 'Notes'). In addition, the company announced that it has completed a partial refinancing of its credit agreement, and in connection with such refinancing, it has entered into a third amendment (the 'Third Amendment') to its existing credit agreement providing for a $2.325 billion term B loan facility maturing in 2031 (the 'New Term B Loans') and an $800 million revolving credit facility maturing in 2030 (subject to customary 'springing' maturity provisions) (the 'New Revolving Credit Facility'). The Notes bear interest at the rate of three-month EURIBOR (with a 0% floor) plus 3.875% per year, reset quarterly, and will mature on January 15, 2031. The Notes were sold to investors at a price of 99.500% of the principal amount thereof. The Notes are guaranteed by the company and each of the company's subsidiaries (other than the Issuers) that are guarantors under the company's credit agreement and are secured on a first priority basis by liens on the same assets that secure the obligations under the company's credit agreement and the company's outstanding senior secured notes. The amortization rate for the New Term B Loans is 1.00% per annum and the first installment shall be payable on September 30, 2025. Pursuant to the Third Amendment, the initial rate of interest applicable to the New Term B Loans is (i) 4.25% for the New Term B Loans that are SOFR Loans and (ii) 3.25% for New Term B Loans that are ABR Loans. The rate of interest applicable to the New Revolving Credit Facility remains the same as that applicable to the existing revolving credit facility. The Third Amendment includes certain other modifications to the credit agreement, including increased financial covenant levels and other changes providing for additional transaction flexibility. The company used the net proceeds from the Notes offering and the New Term B Loans to repay in full the outstanding borrowings under its existing revolving credit facility, to refinance in full the outstanding term A loans due 2027 and term B loans due 2027 and to pay related fees and expenses. The Notes are not registered under the Securities Act of 1933, as amended ('Securities Act'), or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. The Notes were offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act. The Notes were not and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the Notes in Canada must be made on a basis which is exempt from the prospectus requirements of such securities laws. About Bausch + Lomb Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. Forward-looking Statements This news release may contain forward-looking information and statements within the meaning of applicable securities laws (collectively, 'forward-looking statements'). Forward-looking statements may generally be identified by the use of the words 'anticipates,' 'seeks,' 'expects,' 'plans,' 'should,' 'could,' 'would,' 'may,' 'will,' 'believes,' 'potential,' 'pending' or 'proposed' and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb's filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators (including the company's Annual Report on Form 10-K for the year ended Dec. 31, 2024 and its most recent quarterly filings). In addition, certain material factors and assumptions have been applied in making these forward-looking statements, including the assumption that the risks and uncertainties discussed in such filings will not cause actual results or events to differ materially from those described in these forward-looking statements. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
